baber/WOPTO huggingface dataset:
Patent EP-2708844-A1 (EP)
Inventor: ALLEN MATTHEW DAVID
IPC: G01B11/24
Filed: 2013-09-10
Abstract: Disclosed herein is a system having an optically transparent substrate having a first side and a second side that are opposed to each other, a microprocessor, a database, a camera disposed upon the first side of the optically transparent substrate and a source of illumination. The source of illumination is disposed in a ring around the camera on the first side and is operative to illuminate the object disposed on the second side of the optically transparent substrate. Further the camera is in operative communication with the microprocessor and the database. The camera is operative to capture an image of an object disposed upon the second side of the optically transparent substrate. The microprocessor is operative to calculate dimensions and geometry of the object from the image and facilitate acceptance or rejection of the object based upon a standard, a parameter or a calibration chart.
Patent EP-2711858-A1 (EP)
Inventor: COLNOT VINCENT CEDRIC
IPC: G06F21/57
Filed: 2013-09-10
Abstract: Embodiments of a method are disclosed. One embodiment is a method for securely updating firmware in a computing device, in which the computing device includes a host processor and a non-volatile memory. The method involves receiving a double-encrypted firmware image from an external firmware source, wherein the double-encrypted firmware image is generated from firmware that is encrypted a first time using a first crypto-key and then encrypted a second time using a second crypto-key. The method also involves receiving the second crypto-key from an external key source, decrypting the double-encrypted firmware image using the second crypto-key to produce an encrypted firmware image, storing the encrypted firmware image in the non-volatile memory of the computing device, reading the encrypted firmware image from the non-volatile memory of the computing device, decrypting the encrypted firmware image using the first crypto-key, and executing the firmware on the computing device.
Patent EP-2863140-A1 (EP)
Inventor: Christian Thesing
IPC: F24F13/072
Filed: 2013-10-18
Abstract: Die Erfindung betrifft ein Gehäuse (1) einer Lüftungsanlage, mit 2 Wandabschnitten (2,3) wobei jeder Wandabschnitt zumindest eine Kante sowie einen daran angrenzenden Kantenbereich aufweist, wobei die beiden Kantenbereiche der zu verbindenden Wandabschnitte jeweils einen gegenüber der sonstigen Erstreckung des jeweiligen Wandabschnitts winklig ausgerichteten, insbesondere durch einen Abkantprozess erzeugten, Schenkel (4,5) aufweisen, wobei der Schenkel (4) des ersten Wandabschnitts (2) zumindest eine freie Kante sowie wenigstens einen zumindest teilweise entlang der Längserstreckung der Kante an diese Kante angrenzenden Schenkelbereich (6) aufweist und wobei dieser Schenkelbereich (6) zur Verbindung mit dem zweiten Wandabschnitt (3) nach außen umgebogen und federnd als Spannabschnitt ausgebildet ist, so dass der Spannabschnitt mit der Außenseite des Schenkels (4) des nicht umgebogenen Bereichs des Schenkels (4) einen Einführschlitz bildet, wobei der freie Zwischenraum des Einführschlitzes geringer als die Materialstärke des einzuführenden Bereichs des Schenkels (5) des zweiten Wandabschnittes (3) ist, so dass der Spannabschnitt beim Einführen des Schenkels (5) des zweiten Wandabschnittes in den Einführschlitz des ersten Wandabschnittes (2) gegen seine Rückstellkraft nach außen verlagert wird und die beiden Schenkel (4,5) in der Fixierposition durch die Rückstellkraft flächig unter Schaffung einer luftdichten Abdichtung zwischen beiden Wandabschnitten bis zu einem Differenzdruck von bis zu 1.000 Pa gegeneinander gepresst werden.
Patent EP-2722186-A1 (EP)
Inventor: TRONÇON DANIEL
IPC: B41J3/407
Filed: 2013-10-21
Abstract: The machine has a calibration window (66) comprising flanges (210A, 210B) moving between tightened and loosened positions of the window in which central opening (68) is in small and large sizes. An actuator displaces the flanges between the positions, so that the window is in the tight position when an object is transferred, by a transfer unit, from a transport unit to a print station until an end of the object crosses the opening and in the loosened position when the object is transferred from transport unit to the print station.
Patent EP-2743504-A1 (EP)
Inventor: TONEGAWA MASAAKI
IPC: F04B27/18
Filed: 2013-12-09
Abstract: A control valve (1) includes a body (5) having a main passage communicating a discharge chamber with a crankcase and a sub-passage communicating the crankcase with a suction chamber, a main valve provided in the main valve passage, a sub-valve passage provided in the sub-passage, a pressure-sensing section (6) for receiving the suction pressure of the suction chamber and generating a drive force exerted in an opening direction of a main valve in accordance with the magnitude of the suction pressure, and a solenoid (3) for generating a drive force in a closing direction of the main valve in accordance with the amount of current supplied. A valve-opening mechanism used to open the sub-valve by using the drive force of the solenoid is further included. The outside diameter of the body becomes smaller toward the pressure-sensing section side from the solenoid side. The pressure-sensing section, the main valve, the sub-valve, and the solenoid are arranged in this order from one end side of the body. The sub-valve is provided on a side closer to the solenoid where the outside diameter of the body is larger.
Patent EP-2757096-A1 (EP)
Inventor: TSANTRIZOS YOULA S
IPC: A61K31/47
Filed: 2008-09-11
Abstract: Compounds of formula I:
     
wherein  R   4 ,  R   6  and  R   7  are defined herein, are useful as inhibitors of HIV replication.
Patent EP-2863230-A1 (EP)
Inventor: LAGROST LAURENT
IPC: G01N33/68
Filed: 2013-10-18
Abstract: The present invention relates to a method for predicting the risk of sepsis for a patient undergoing surgery, comprising the preoperative step of measuring preoperative cholesterolemia and the postoperative step of measuring IL8 or PCT levels of said patient, wherein low preoperative cholesterolemia and high postoperative IL8 or PCT level is associated with an increased risk of sepsis.
Patent EP-2680097-A1 (EP)
Inventor: BERTRAM ANDRE
IPC: G05D1/00
Filed: 2013-06-04
Abstract: The self-propelled cleaning device has an optical sensor (6) for detecting an environment of the cleaning device, where a control device (7) is arranged to analyze signals from the optical sensor for detecting gestures of a user (9) and for controlling the cleaning device by using recognized gestures. The optical sensor is arranged on an upper side of the cleaning device and is designed as an imaging camera with a wide field of view. An optical projection device projects a predetermined pattern of light in the vicinity of the cleaning device. An independent claim is included for a method for operating a self-propelled cleaning device.
Patent EP-2807497-A1 (EP)
Title: Antenne d'émission-réception à résonance multiples pour la génération d'images rm
Inventor: LEUSSLER CHRISTOPH
IPC: G01R33/36
Filed: 2013-01-03
Abstract: La présente invention concerne une antenne d'émission et/ou de réception RF/RM à résonance double ou multiples (1, 2) en particulier sous la forme d'une antenne planaire ou d'une antenne réseau volumique (également appelée réseau d'antennes) pour la génération d'images RM d'au moins deux noyaux différents tels que  1 H,  19 F,  3 He,  13 C,  23 Na ou d'autres noyaux présentant des fréquences de Larmor différentes. Fondamentalement, l'antenne est couplée au moyen d'un dispositif de couplage inductif (LI) avec des canaux d'émission/de réception (TR) associés. Par un tel couplage inductif, le réglage et l'adaptation de l'antenne à des fréquences résonantes différentes sont plus faciles à obtenir que dans le cas d'une connexion galvanique. En outre, l'invention concerne un appareil d'imagerie RM comprenant une telle antenne d'émission et/ou de réception à résonance double ou multiple.
Patent EP-2834226-A1 (EP)
Inventor: DEHMLOW HENRIETTA
IPC: C07D401/04
Filed: 2013-04-02
Abstract: This invention relates to novel 1,2-pyridazines, 1,6-pyridazines or pyrimidines of the formula I wherein B 1  to B 3  and R 1  to R 7  are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and may therefore be useful as medicaments for the treatment of diseases such as type II diabetes.
Patent EP-2836613-A1 (EP)
Title: Verfahren und vorrichtung zur brikettherstellung
Inventor: HECKMANN HADO
IPC: C22B1/245
Filed: 2013-03-28
Abstract: Verfahren zur Herstellung eines Kohlenstoffträger (2) enthaltenden Briketts, wobei die Kohlenstoffträger (2) mit einem Bindemittelsystem (3) einer Vermischung unter Zugabe von Wasserdampf unterzogen werden und das dabei erhaltene Gemisch einer Pressung zu Briketts unterzogen wird. Dabei wird zumindest einer der Schritte - Trocknung der Kohlenstoffträger (2) vor der Vermischung, - Einstellung der Temperatur der mit dem Bindemittelsystem zu vermischenden Kohlenstoffträger (2) vor der Vermischung in einen vordefinierten Temperaturbereich, - Wärmebehandlung der Briketts nach der Pressung, mittels direkter oder indirekter Wechselwirkung mit einem überhitzten Wasserdampf durchgeführt. Dabei anfallender Abdampf wird zumindest als Teilmenge des bei der Vermischung zugegebenen Wasserdampfes genutzt. Eine Vorrichtung zur Durchführung eines solchen Verfahrens weist eine Vorrichtung zur direkten oder indirekten Wechselwirkung mit Wasserdampf auf, von der eine Abdampfleitung ausgeht, die direkt oder indirekt in die Vermischungseinrichtung mündet.
Patent EP-2809357-A1 (EP)
Title: Procédé d'utilisation de l'adénosine et du dipyridamole dans des épreuves de stress pharmacologique, à l'aide de compositions spécifiques, de formes pharmaceutiques unitaires et de trousses
Inventor: GORNY PHILIPPE
IPC: A61K31/519
Filed: 2013-01-29
Abstract: On décrit des procédés permettant de détecter la présence et/ou d'évaluer la gravité d'une ischémie myocardique au cours d'épreuves de stress pharmacologique, par administration d'une composition pharmaceutique comprenant de l'adénosine et du dipyridamole. Ces procédés autorisent l'utilisation combinée de dipyridamole administré comme bolus, et d'adénosine administrée sous forme d'infusion, le dosage de chaque composé étant inférieur à son dosage respectif lorsqu'il est utilisé seul. Les procédés de l'invention sont utiles pour exploiter le pouvoir vasodilatateur de l'adénosine à des doses auxquelles les effets secondaires liés à l'adénosine sont considérablement réduits, tout en réalisant une perfusion coronaire optimale. L'invention concerne également des compositions, des formes pharmaceutiques unitaires, et des trousses utiles dans la mise en oeuvre desdits procédés.
Patent EP-2847184-A1 (EP)
Inventor: DUBOST CHRISTOPHE
IPC: C07D405/12
Filed: 2013-05-06
Abstract: La présente invention concerne de nouveaux 1-méthyl-3-dihalogénométhyl-5-halogénopyrazole (thio)benzofuranyle carboxamides, des procédés pour préparer ces composés, des compositions comprenant ces composés, et leur utilisation en tant que composés biologiquement actifs, en particulier pour lutter contre les micro-organismes nuisibles, pour la protection des cultures et pour la protection des matériaux.
Patent EP-2885280-A1 (EP)
Inventor: STEFANSKI TOMASZ
IPC: A61K31/421
Filed: 2013-03-28
Abstract: The present invention relates to the new chemical compounds containing (Z)-1,2- diphenylethene moiety in the structures, particularly the new derivatives of cis-stilbene, the new derivatives of 4,5-diphenyl-1,3-oxazole, the new derivatives of 1-methyl-4,5-diphenyl-1H-imidazole and pharmaceutically acceptable salts thereof. The invention relates also to the application of aforementioned compounds as a microtubule-interfering agents (MIAs). The new derivatives, because of their potential antimitotic and antiangio-genic activity, can be used as ingredients in the preparations used in the treatment of cancer.
Patent EP-2854809-A1 (EP)
Inventor: KAETHER CHRISTOPH
IPC: C07D215/54
Filed: 2013-06-03
Abstract: The invention relates to dihydropyridine compounds as inhibitors of the notch signalling pathway and/or inhibitors of secretion for the treatment of secretion-dependent disease, such as cancer or senescence-related ageing, in addition to pharmaceutical compositions thereof and methods of treatment.
Patent EP-2855534-A1 (EP)
Inventor: DAO VITHUY
IPC: D06M11/30
Filed: 2013-06-03
Abstract: The present invention concerns a method for obtaining a solid material based on a polymer of which the cellobiose units display the following features: at least some of the cellobiose units have at least one carboxylic acid function carried by the C 6  carbon atom, the other C 6  carbon atoms carrying a primary alcohol function; and at least some of the cellobiose units have at least one of the two rings open between the C 2  and C 3  carbon atoms, the other C 2  and C 3  carbon atoms forming a ring and carrying an alcohol function. A material of this nature, advantageously a textile, can be used as a compress.
Patent EP-2864920-A1 (EP)
Inventor: MARTIN FLORIAN
IPC: G16B40/20
Filed: 2013-06-21
Abstract: Described herein are systems and methods for correcting a data set and classifying the data set in an integrated manner. A training data set, a training class set, and a test data set are received. A first classifier is generated for the training data set by applying a machine learning technique to the training data set and the training class set, and a first test class set is generated by classifying the elements in the test data set according to the first classifier. For each of multiple iterations, the training data set is transformed, the test data set is transformed, and a second classifier is generated by applying a machine learning technique to the transformed training data set. A second test class set is generated according to the second classifier, and the first test class set is compared to the second test class set.
Patent EP-2877644-A1 (EP)
Inventor: DE LUCA EGIDIO
IPC: E04F13/14
Filed: 2013-05-23
Abstract: Construction element for walls and wall lining comprising at least one layer of lining material (11) and one layer of lightened natural lime (12) attached to the lining material (11) by drying to form a single body.
Patent EP-2805254-A1 (EP)
Inventor: TSE DAVID
IPC: G06Q10/10
Filed: 2013-01-16
Abstract: Presence-based synchronization manages updates among concurrent collaborators based on the presence information of each collaborator within a shared document of a collaboration environment. A collaborator's edits to a page of a shared document can be synchronized more frequently when other collaborators are accessing the same page. In contrast, the collaborator's edits to a page of a shared document can be synchronized less frequently when no other collaborators are accessing that page. Further, the manner of the collaborator's presence within the shared document may influence the synchronization rate - collaborating users within an online meeting may synchronize more frequently than a single user who is not actively collaborating with other users. In one implementation, other maintenance activities within the shared document (e.g., garbage collection) may be influenced by the presence information of collaborators within the collaboration environment.
Patent EP-2890509-A1 (EP)
Inventor: BEWLAY BERNARD PATRICK
IPC: C04B28/06
Filed: 2013-08-02
Abstract: The disclosure relates generally to mold compositions comprising calcium aluminate and calcium titanate. The disclosure also relates to methods of molding and the articles so molded using the mold compositions. More specifically, the disclosure relates to calcmm a!uminate/calcium titanate mold compositions and methods for casting titanium-containing articles, and the titanium-containing articles so molded.
Patent EP-2954524-A1 (EP)
Inventor: ATTI VENKATRAMAN SRINIVASA
IPC: G10L21/038
Filed: 2013-08-06
Abstract: A particular method includes determining, based on an inter-line spectral pair (LSP) spacing corresponding to an audio signal, that the audio signal includes a component corresponding to an artifact-generating condition. The method also includes, in response to determining that the audio signal includes the component, adjusting a gain parameter corresponding to the audio signal. For example, the gain parameter may be adjusted via gain attenuation and/or gain smoothing.
Patent EP-2823748-A1 (EP)
Inventor: ITO RYOSUKE
IPC: A61B5/00
Filed: 2013-03-06
Abstract: An optical measuring device and a fiber bundle association method, capable of associating positions of respective optical fibers of a fiber bundle with a simple configuration, are provided. An optical measuring device 1 includes an association unit which, when light having an intensity gradient around an illumination fiber 341 is projected to an end face of a distal end portion 33 of a measurement probe 3, associates the respective signal intensities of light-receiving fibers 342 detected by a detection unit 24, with distances from the illumination fiber 341 to the respective light-receiving fibers 342 on the end face of the distal end portion 33 of the measurement probe 3.
Patent EP-2895416-A1 (EP)
Title: Betätigungselement für eine fangvorrichtung
Inventor: MINATTA MASSIMO
IPC: B66B5/22
Filed: 2013-08-29
Abstract: Vorrichtung zum Aktivieren und Deaktivieren einer Fangvorrichtung einer Aufzugskabine während der Montage einer Aufzugsanlage, wobei die Vorrichtung ein Betätigungselement (1, 1') aufweist, welches dazu vorgesehen ist, an einer Kabine (30) befestigt zu werden, wobei das Betätigungselement (1, 1') in einer ersten Position (P1) derart auf die Fangvorrichtung (40) wirkt, dass die Fangvorrichtung aktiviert ist und wobei das Betätigungselement (1, 1') bei Betätigung durch einen Monteur in eine zweite Position (P2) bringbar ist, in der es keine Wirkung auf die Fangvorrichtung (40) ausübt.
Patent EP-2891373-A1 (EP)
Inventor: MORIOKA YUICHI
IPC: H04W72/04
Filed: 2013-08-29
Abstract: A mobile communications system communicates data to and/or from mobile communications devices. The mobile communications system provides a wireless access interface for communicating data to and/or from the mobile communications devices, the wireless access interface providing on a downlink first carrier, the first carrier providing a plurality of communications resource elements across a first frequency range for communicating data, and providing a plurality of communications resource elements within a second frequency range which is within and smaller than the first frequency range. The wireless access interface provided by the base stations includes a plurality of time divided sub-frames, each sub-frame including the plurality of communications resource elements of the first frequency range and the plurality of the communications resource elements of the second frequency range, and each sub-frame includes a first wideband control channel in a part of each sub- frame having a bandwidth corresponding substantially to the first frequency range, and a second narrow band control channel in a second part of each sub-frame and having a bandwidth which is less than the first wideband control channel and a duration of the second narrow band control channel within the sub-frame is greater than a duration of the first wideband control channel within the sub- frame. The second narrow band control channel is configured for communicating control information to both the first mobile communications devices and the second mobile communications devices and forms part of the plurality of the communications resource elements of the second frequency range of the second carrier. By arranging for the narrow band control channel to be within the virtual carrier and to communicate control information to both first full capability communications devices and second reduced capability communications devices, the second reduced capability devices can access the narrow band control channel which is shared with the first full-capability mobile devices. This arrangement makes more use of the communications resources available to the communications system.
Patent EP-2874667-A1 (EP)
Inventor: ST GERMAIN MARK DAVID
IPC: A61L2/10
Filed: 2013-07-09
Abstract: A disinfection device includes a reflective surface (107) configured to direct light at a plurality of angles toward a target surface (108). The reflective surface forms a partial enclosure and has end portions (110). A light source (104) is disposed within the partial enclosure, wherein at least a portion of the light source is positioned within the partial enclosure such that light from the light source is reflected off the end portions to provide an angle of incidence on the target surface to treat an under-shadow region of an object or an uneven target surface.
Patent EP-2917615-A1 (EP)
Title: Kolbenring mit variierender scheitelpunktlinie
Inventor: MITTLER RICHARD
IPC: F16J9/20
Filed: 2013-09-23
Abstract: Erfindungsgemäß wird ein Kolbenring (1) mit einer außenseitigen Lauffläche (3), zwei Flanken (5, 6) und einer innenseitigen Umfangsfläche (7) bereitgestellt. Die Lauffläche (3) weist eine Profilierung auf. Das Profil der Lauffläche ist im Wesentlichen konvex ballig (10) ausgebildet und hat einen Scheitelpunkt (B1). Die axiale Position des Scheitelpunktes (B1) variiert in Umfangsrichtung periodisch.
Patent EP-2872622-A1 (EP)
Title: Utilisation de molécules agonistes ret pour protocoles d'expansion de cellules souches hématopoïétiques et thérapie de transplantation, et kit d'agonistes ret
Inventor: VEIGA FERNANDES JOSÉ HENRIQUE
IPC: A61K35/28
Filed: 2013-06-26
Abstract: La présente invention concerne l'utilisation de molécules agonistes RET ‑ un récepteur tyrosine kinase transmembranaire - dans le cadre de protocoles d'expansion de cellules souches hématopoïétiques et d'une thérapie de transplantation de ces cellules. Les molécules de signalisation du RET sont exprimées par des cellules souches hématopoïétiques, et l'ablation du RET entraîne la réduction du nombre de cellules souches hématopoïétiques. Les signaux RET procurent des cellules souches hématopoïétiques avec des signaux survivants Bcl2 et Bcl2l1 critiques, en aval de l'activation de la kinase p38/MAP et de CREB. Par conséquent, l'expression forcée de cibles RET Bcl2 ou Bcl2l1 en aval est suffisante pour restaurer l'activité des progéniteurs nuls RET in vivo. On constate de manière remarquable que l'activation de RET améliore la survie ou le maintien des cellules souches hématopoïétiques, ainsi que l'efficacité de la transplantation in vivo, ouvrant ainsi de nouvelles perspectives pour l'utilisation de l'agoniste RET dans l'expansion des cellules souches hématopoïétiques et les protocoles de transplantation de ces cellules. En outre, la présente invention décrit un kit comprenant des molécules agonistes RET, à utiliser dans des protocoles d'expansion de cellules souches hématopoïétiques et en thérapie de transplantation de ces cellules.
Patent EP-2831283-A1 (EP)
Title: Procédés et composition permettant le séquençage d'acides nucléiques modifiés
Inventor: KORLACH JONAS
IPC: G01N33/48
Filed: 2013-03-18
Abstract: Des procédés, des compositions et des systèmes sont prévus pour la caractérisation d'acides nucléiques modifiés. Dans certains modes de réalisation préférés, l'invention concerne des procédés de séquençage de molécule unique pour l'identification des nucléotides modifiés dans les séquences d'acide nucléique. Les modifications détectables grâce aux procédés de l'invention concernent les bases chimiquement modifiées, les bases modifiées par voie enzymatique, les sites de base a, les bases non naturelles, les structures secondaires, et les agents liés à un acide nucléique de matrice.